Machine Learning

A new gene therapy has helped completely blind patients with Retinitis Pigmentosa regain light perception, offering hope to millions with inherited blindness.

A landmark Carnegie Hall concert saw young U.S. and Chinese musicians use AI to compose new works, blending tradition with tech to foster global unity.

McEwen Inc. completes its acquisition of Golden Lake, integrating the Jewel Ridge project to create a long-life gold mining complex in Nevada's core.

With cash burn rising, Summit Therapeutics races toward a November FDA decision on its novel cancer drug ivonescimab and a major data reveal at ASCO.

With a new $19 entry-level plan and a scalable ecosystem, MioCommerce is making a strategic play to equip service businesses from solo startups to large teams.

Following a record-breaking quarter, Enova's executives will detail their AI-powered growth engine and future outlook at the Needham investor conference.

In a move toward greater transparency, Carequality invites external experts to help steer the future of national health data exchange and interoperability.

A new partnership aims to make powerful FPGA chips accessible to hobbyists and startups, potentially sparking a new wave of hardware innovation.

A new partnership between Context Networks and BetSource aims to unlock millions in ad revenue from casinos, hotels, and tribal enterprises.

A new AI device lets you see the world through your pet's eyes, creating a media frenzy. But the data it collects may be the most valuable asset of all.

A new book argues modern genomics is stuck on a 'parts list.' Can an architectural approach called 'Deterministic Convergence' build a better future for health?

An executive's industry award signals a major shift, as artificial intelligence is deployed to combat the staggering administrative waste in U.S. healthcare.

Once a photography giant, Fujifilm's pivot to healthcare and tech has earned it a top spot on TIME's Most Influential list. Here’s the story of its rebirth.

A new 'growth-governance' standard challenges the costly paid ad model, promising clinics sustainable growth through data integrity and patient loyalty.

VectorBuilder tackles key AAV therapy hurdles in ophthalmology, aiming to boost consistency and unlock new treatments for blinding genetic diseases.

Nanometrology leader Park Systems buys probe maker Rocky Mountain Nanotechnology, a strategic vertical integration securing critical components for future tech.

A new AI platform promises to fix billions in revenue loss from complex cardiac coding, but will it empower or replace human experts in the process?

A new peer-reviewed study shows Glucotrack's fully implantable glucose monitor is accurate for 240 days, a key step towards a 3-year, no-wearable future.

Hannover Re US names Kelly Rabin Chief Actuary, a strategic move leveraging her diverse insurtech and consulting background to drive innovation.

A new collaboration leverages a vast cord blood bank and advanced AI to create off-the-shelf cell therapies, promising a new era in regenerative medicine.